Study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant
A study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthStudy from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant
View Premium plansBrowse free archive reportsA study from the Public Health England shows that the vaccine developed by Pfizer is 96% effective against hospitalizations from the Delta variant, while the AstraZeneca–Oxford vaccine is 92% effective.